Amorphous nano morin outperforms native molecule in anticancer activity and oral bioavailability

References

• He Q, Jia Z, Zhang Y, et al. Morin hydrate promotes inner ear neural stem cell survival and differentiation and protects cochlea against neuronal hearing loss. J Cell Mol Med. 2017;21(3):600–608.
   PubMed Web of Science ®Google Scholar
• Gopal JV. Morin hydrate : botanical origin, pharmacological activity and its applications : a mini-review. Pharmacogn J. 2013;5:123–126.
   Google Scholar
• Jangid AK, Pooja D, Kulhari H. Determination of solubility, stability and degradation kinetics of morin hydrate in physiological solutions. RSC Adv. 2018;8(50):28836–28842.
   Web of Science ®Google Scholar
• Park C, Lee WS, Go S, et al. Morin, a flavonoid from Moraceae, induces apoptosis by induction of BAD protein in human leukemic cells. Int J Mol Sci. 2015;8733:645–659.
   Google Scholar
• Janeiro P, Maria A, Brett O. Solid state electrochemical oxidation mechanisms of Morin in aqueous media. Electroanalysis. 2005;17(9):733–738.
   Web of Science ®Google Scholar
• El-Haddad AE, Sheta NM, Boshra SA. Isolation, formulation, and efficacy enhancement of Morin emulsified carriers against lung toxicity in rats. AAPS PharmSciTech. 2018;19(5):2346–2357.
   PubMed Web of Science ®Google Scholar
• Khadka P, Ro J, Kim H, et al. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci. 2014;9(6):304–316.
   Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems : recent developments and future prospects. J Nanobiotechnol. 2018;16(1):33–71.
   PubMedGoogle Scholar
• Sansone F, Sansone F, Esposito T, et al. Particle technology applied to a lactose/NaCMC blend : production and characterisation of a novel and stable spray-dried ingredient Particle technology applied to a lactose/NaCMC blend : production and characterization of a novel and stable spray-drie. Powder Technol. 2018;329:304–312.
   Web of Science ®Google Scholar
• Ebbesen M, Jensen TG. Nanomedicine: techniques, potentials, and ethical implications. J Biomed Biotechnol. 2006;2006(5):51516.
   PubMedGoogle Scholar
• Yang W, Peters JI, Williams RO. Inhaled nanoparticles – a current review. Int J Pharm. 2008;356(1–2):239–247.
   PubMed Web of Science ®Google Scholar
• Geng T, Banerjee P, Lu Z, et al. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: physicochemical and pharmacokinetic investigation. Eur J Pharm Sci. 2017;109:200–208.
   PubMed Web of Science ®Google Scholar
• Zhang J, Peng Q, Shi S, et al. Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. Int J Nanomed. 2011;6:3405–3414.
   PubMed Web of Science ®Google Scholar
• Waddad AY, Abbad S, Yu F, et al. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm. 2013;456(2):446–458.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Patwari J, Dasgupta S. Complexation with human serum albumin facilitates sustained release of Morin from polylactic-co-glycolic acid nanoparticles. J Phys Chem B. 2017;121(8):1758–1770.
   PubMed Web of Science ®Google Scholar
• Abbad S, Abbad S, Waddad AY, et al. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of Morin hydrate. Int J Nanomed. 2015;10:305–320.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Bag S, Singha Roy A, et al. RSC advances solubility enhancement of morin and epicatechin through encapsulation in an albumin based nanoparticulate system and their anticancer activity against the MDA-MB-468 breast cancer cell line. RSC Adv. 2016;6(103):101415–101429.
   Web of Science ®Google Scholar
• Sharma D, Singh M, Kumar P, et al. Development and characterization of morin hydrate loaded microemulsion for the management of Alzheimer’s disease. Artif Cells Nanomed Biotechnol. 2017;45(8):1620–1630.
   PubMed Web of Science ®Google Scholar
• Sultana F, Neog MK, Rasool MK. Targeted delivery of morin, a dietary bioflavanol encapsulated mannosylated liposomes to the macrophages of adjuvant-induced arthritis rats inhibits inflammatory immune response and osteoclastogenesis. Eur J Pharm Biopharm. 2017;115:229–242.
   PubMed Web of Science ®Google Scholar
• Kumar A, Agraval H, Gupta N, et al. Designing of fatty acid-surfactant conjugate based nanomicelles of morin hydrate for simultaneously enhancing anticancer activity and oral bioavailability. Colloids Surf B Biointerfaces. 2019;175:202–211.
   PubMed Web of Science ®Google Scholar
• Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arabian J Chem. 2019;12(7):908–931.
   Web of Science ®Google Scholar
• Desai N. Challenges in development of nanoparticle-based therapeutics. Aaps J. 2012;14(2):282–295.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Sponchioni M, Morbidelli M, et al. Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation. Nanoscale. 2018;10(48):22701–22719.
   PubMed Web of Science ®Google Scholar
• Shin S, Song I, Um S. Role of physicochemical properties in nanoparticle toxicity. Nanomaterials (Basel). 2015;5(3):1351–1365.
   PubMedGoogle Scholar
• Sharma A, Madhunapantula SV, Robertson GP. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol. 2012;8(1):47–69.
   PubMed Web of Science ®Google Scholar
• Taira MC, Chiaramoni NS, Pecuch KM, et al. Stability of liposomal formulations in physiological conditions for oral drug delivery. Drug Deliv. 2004;11(2):123–128.
   PubMed Web of Science ®Google Scholar
• Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 2008;60(6):734–746.
   PubMed Web of Science ®Google Scholar
• Lopes DG, Koutsamanis I, Becker K, et al. Microphase separation in solid lipid dosage forms as the cause of drug release instability. Int J Pharm. 2017;517(1–2):403–412.
   PubMedGoogle Scholar
• Nair A, Khunt D, Misra M. Application of quality by design for optimization of spray drying process used in drying of Risperidone nanosuspension. Powder Technol. 2019;342:156–165.
   Web of Science ®Google Scholar
• Yue P, Li Y, Wan J, et al. Study on formability of solid nanosuspensions during nanodispersion and solidification : I. Novel role of stabilizer/drug property. Int J Pharm. 2013;454(1):269–277.
   PubMed Web of Science ®Google Scholar
• Bi C, Miao XQ, Chow SF, et al. Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution. Nanomedicine. 2017;13(3):943–953.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang C, Zhao J, et al. A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability. J Colloid Interface Sci. 2017;485:91–98.
   PubMed Web of Science ®Google Scholar
• Singh MK, Pooja D, Ravuri HG, et al. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability. Phytomedicine. 2018;40:48–54.
   PubMed Web of Science ®Google Scholar
• Zulmira L, Lobato J, Marcelo R, et al. Nanosuspension of quercetin : preparation, characterization and effects against Aedes aegypti larvae. Rev Brasil Farmacognosia. 2018;28(5):618–625.
   Web of Science ®Google Scholar
• Hong C, Dang Y, Lin G, et al. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization : an in vitro and in vivo evaluation. Int J Pharm. 2014;477(1–2):251–260.
   PubMed Web of Science ®Google Scholar
• Qian YS, Ramamurthy S, Candasamy M, et al. Production, characterization and evaluation of kaempferol nanosuspension for improving oral bioavailability. CPB. 2016;17(6):547–549.
   Google Scholar
• Azad M, Afolabi A, Bhakay A, et al. Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer. Eur J Pharm Biopharm. 2015;94:372–385.
   PubMed Web of Science ®Google Scholar
• Studart AR, Amstad E, Gauckler LJ. Colloidal stabilization of nanoparticles in concentrated suspensions. Langmuir. 2007;23(3):1081–1090.
   PubMed Web of Science ®Google Scholar
• Ehab M, Lamprecht A. Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation. Int J Pharm. 2013;456(1):135–142.
   PubMedGoogle Scholar
• Pooja D, Panyaram S, Kulhari H, et al. Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity. Carbohydr Polym. 2014;110:1–9.
   PubMed Web of Science ®Google Scholar
• Pooja D, Panyaram S, Kulhari H, et al. Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier. Int J Biol Macromol. 2015;80:48–56.
   PubMed Web of Science ®Google Scholar
• Yang H, Teng F, Wang P, et al. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability. Int J Pharm. 2014;477(1–2):88–95.
   PubMed Web of Science ®Google Scholar
• Alqurshi A, Chan KLA, Royall PG. In-situ freeze-drying – forming amorphous solids directly within capsules : an investigation of dissolution enhancement for a poorly soluble drug. Sci Rep. 2017;7:1–16.
   PubMed Web of Science ®Google Scholar
• Aditya NP, Hamilton IE, Noon J, et al. I. Microwave-assisted nanonization of poorly water-soluble curcumin. ACS Sustain Chem Eng. 2019;7(11):9771–9781.
   Web of Science ®Google Scholar
• Zhu L, Zhu L, Murtaza A, et al. Ultrasonic processing induced activity and structural. Molecules. 2019;24(10): 1910–1922.
   Web of Science ®Google Scholar
• Kakran M, Shegokar R, Sahoo NG, et al. Fabrication of quercetin nanocrystals: comparison of different methods. Eur J Pharm Biopharm. 2012;80(1):113–121.
   PubMed Web of Science ®Google Scholar
• Tian X, Li H, Zhang D, et al. Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies. Colloids Surf B Biointerfaces. 2013;108:29–33.
   PubMed Web of Science ®Google Scholar
• Arey JS, Gschwend PM. Estimating partition coefficients for fuel-water systems: developing linear solvation energy relationships using linear solvent strength theory to handle mixtures. Environ Sci Technol. 2005;39(8):2702–2710.
   PubMed Web of Science ®Google Scholar
• Harmon P, Galipeau K, Xu W, et al. Mechanism of dissolution-induced nanoparticle formation from a copovidone-based amorphous solid dispersion. Mol Pharm. 2016;13(5):1467–1481.
   PubMedGoogle Scholar